Versant Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98K Buy
+540
New +$3.3K ﹤0.01% 2396
2025
Q3
Sell
-288
Closed -$2.68K 2706
2025
Q2
$2.68K Hold
288
﹤0.01% 2329
2025
Q1
$2.81K Hold
288
﹤0.01% 2216
2024
Q4
$3.49K Buy
288
+165
+134% +$2K ﹤0.01% 1925
2024
Q3
$1.35K Buy
+123
New +$1.25K ﹤0.01% 1676
2024
Q2
Sell
-94
Closed -$768 1995
2024
Q1
$768 Buy
+94
New +$771 ﹤0.01% 1597
2023
Q4
Sell
-25
Closed -$428 1994
2023
Q3
$428 Sell
25
-3
-11% -$59 ﹤0.01% 1724
2023
Q2
$650 Buy
+28
New +$547 ﹤0.01% 1748

Other funds holding REPL

Versant Capital Management's REPL Position: Q2 2026 in Review

Versant Capital Management opened a new position in Replimune Group (REPL) in Q2 2026: 540 shares worth $5.98K. The stake represents ﹤0.01% of the portfolio and ranks #2396 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in REPL as recently as Q2 2025.

Versant Capital Management first reported a position in REPL in Q2 2023 and has held it in 8 quarters since. 12 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Versant Capital Management held 540 shares of Replimune Group worth $5.98K as of Q2 2026.
  • Replimune Group was a new Versant Capital Management position in Q2 2026.
  • Replimune Group made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2396 holding.
  • Versant Capital Management first reported a position in Replimune Group in Q2 2023 and has held it in 8 quarters since.
  • 12 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.